Chronic Disease
Our work in Chronic Disease
-
Congress Should End Dialysis Companies’ Third-Party Games with Insurance Coverage
A new op-ed in STAT highlights practices by dialysis facilities where they try to push patients into individual market plans by financing patients’ premiums for those plans
-
How Sick Is My Cohort of Patients? A General Approach to Identify Chronic Conditions
This presentation discusses a SAS(r) macro that applies Chronic Conditions Warehouse-like rules to any data set either from insurance claims, or electronic health records (EHR) containing a full picture of diagnoses and procedures from patient medical visits.
Categorized in -
Association Between Exenatide Use and Incidence of Alzheimer’s Disease
Exenatide use is associated with a reduced incidence of AD among Medicare beneficiaries aged 65 years or older with type II diabetes.
Categorized in -
Associations of Intensive Lifestyle Intervention in Type 2 Diabetes With Health Care Use, Spending, and Disability
Is an intensive lifestyle intervention for type 2 diabetes associated with long-term health care use and Medicare spending?
Categorized in -
Making Progress in Cancer Diagnostics: Clinical Practice and Policy
Join the Health, Medicine and Society Program of the Aspen Institute and the USC Schaeffer Center for a webinar on new clinical advances in cancer screening and the policy issues surrounding access to and adoption of these advances.
-
Changes in Health Services Use Among Commercially Insured US Populations During the COVID-19 Pandemic
The researchers examine changes in health care use during the first 2 months of the COVID-19 pandemic in March and April of 2020 relative to March and April of 2019 and 2018, and to examine whether changes in use differ by patient’s zip code–level race/ethnicity or income.
Categorized in -
For the Sake of Kidney Patients, Vote No on Proposition 23
As a kidney doctor and health policy researcher, I am appalled that patients have become a bargaining chip in a game that could result in massive dialysis shortages, increased costs, and death.
Categorized in -
Improved Survival for Individuals with Common Chronic Conditions in the Medicare Population
It is well established that the United States lags behind peer nations in life expectancy, but it is less established that there is heterogeneity in life expectancy trends. We compared mortality trends from 2004 to 2014 for the United States with 17 high-income countries for persons under and over 65. The United States ranked last […]
Categorized in -
The “Advancing American Kidney Health” Executive Order: Challenges and Opportunities for the Large Dialysis Organizations
This perspective in the American Journal of Kidney Diseases examines how the “Advancing American Kidney Health” Executive Order (AAKH) might reshape the US dialysis market.
Categorized in -
Lifetime Burden of Adult Congenital Heart Disease in the USA Using a Microsimulation Model
There is a significant burden of disease among individuals with CHD; the disease affects quality of life, disability, life expectancy, medical spending, chronic disease, as well as employment and education outcomes.
Categorized in